News

NURO

NueroMetrix's (NURO): 100% Drug-Free Pain Relief using Nuerotechnology

Stephen L Kanaval | Equities.com |

​NeuroMetrix, Inc. (NURO), is an MIT-tech brainchild, develops wearable medical technology and most recently have launched the FDA-approved and well-reviewed, Quell.


NeuroMetrix (NURO): Quell Wearable Pain Relief Device Showcased at NYC Event

Bolton Flautt | Equities.com |

If a device is wearable and adjustable by an easy to use app, the likelihood for me to try out the device increases. NeuroMetrix has taken these factors into consideration when designing Quell


How Apple's Win Over Samsung Affects the Future of the Mobile Market

Equities Editors Desk | Equities.com |

While Apple's (AAPL) patent win over Samsung (SSNLF) was an obvious blow to both the Galaxy S phonemaker and Google (GOOG), which develops the popular Android operating system, the extent to which


Blockchain in Fintech - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Financial Market Infrastructure


Events

Sohn Investment Conference

Wall Street’s best and brightest investors participate in this unique, “must attend” event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset…

Learn more